SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

29 Oct 2024 Evaluate
The company witnessed a 14.84% growth in the revenue at Rs. 2082.60 millions for the quarter ended September 2024 as compared to Rs. 1813.52 millions during the year-ago period.Modest increase of 21.89% in the Net Profit was reported from. 478.70 millions to Rs. 583.49  millions.The company reported a good operating profit of 815.60 millions compared to 708.37 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2082.60 1813.52 14.84 3711.59 3608.93 2.84 7115.98 7209.82 -1.30
Other Income 120.74 82.13 47.01 207.89 132.76 56.59 288.60 239.56 20.47
PBIDT 815.60 708.37 15.14 1345.38 1348.56 -0.24 2580.90 2430.45 6.19
Interest 0.21 0.43 -51.16 0.48 0.91 -47.25 1.61 13.59 -88.15
PBDT 815.39 707.94 15.18 1344.90 1347.65 -0.20 2481.86 2416.86 2.69
Depreciation 46.15 64.68 -28.65 80.97 125.18 -35.32 280.91 250.74 12.03
PBT 769.24 643.26 19.58 1263.93 1222.47 3.39 2200.95 2166.12 1.61
TAX 185.75 164.56 12.88 302.67 302.56 0.04 563.44 565.84 -0.42
Deferred Tax 8.25 10.06 -17.99 27.67 4.06 581.53 21.44 7.84 173.47
PAT 583.49 478.70 21.89 961.26 919.91 4.50 1637.51 1600.28 2.33
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 39.16 39.06 0.26 36.25 37.37 -3.00 36.27 33.71 7.59

Blue Jet Healthcare Share Price

416.60 8.85 (2.17%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×